White label ELPA - ClinicalTrials.eu

Study of Lutetium (177Lu) Oxodotreotide, Carboplatin, Etoposide, and Atezolizumab in Newly Diagnosed Extensive Stage Small Cell Lung Cancer Patients

Not recruiting

1 1 1 1
Investigated Diseases:
- Small cell lung cancer extensive stage
Investigated Drugs:
+2
Baricitinib Compared with Adalimumab and Etanercept in Patients with Rheumatoid Arthritis

Not recruiting

3 1 1 1
Investigated Diseases:
- Rheumatoid arthritis
Investigated Drugs:
+9
Tulisokibart in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease

Not recruiting

2 1
Investigated Diseases:
- Systemic sclerosis pulmonary
Investigated Drugs:
- Tulisokibart
+2
Pharmacokinetics of Intravenous Lidocaine Hydrochloride in Young and Elderly Patients Undergoing Anesthesia

Not recruiting

3 1 1 1
Investigated Drugs:
- Lidocaine Hydrochloride
Faricimab for Choroidal Neovascularization Secondary to Pathologic Myopia in Patients with Pathologic Myopia

Not recruiting

3 1 1 1
Investigated Diseases:
- Choroidal neovascularisation
Investigated Drugs:
- Faricimab
- Ranibizumab
Study of linaprazan glurate and lansoprazole to maintain healing in patients with erosive esophagitis caused by acid reflux disease

Not recruiting

3 1 1
Investigated Drugs:
- Lansoprazole
- LINAPRAZAN GLURATE
A study to evaluate the efficacy and safety of zenagamtide in people with obesity

Not recruiting

3 1
Investigated Diseases:
- Obesity
+2
An exploratory study to evaluate the effect of rimonabant on hand function in patients with cervical spinal cord injury

Not recruiting

1 1 1
A study comparing the effectiveness of vorolanib and aflibercept in patients with diabetic macular edema

Not recruiting

3 1 1 1
Investigated Diseases:
- Diabetic retinal oedema
Investigated Drugs:
- VOROLANIB
- Aflibercept
A study to evaluate the efficacy and safety of MET097 in people with obesity or overweight.

Not recruiting

3 1

+2

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies